Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the ...

Rhythm Pharmaceuticals (RYTM) announced the presentation of new, real-world data that showed four pediatric patients with acquired hypothalamic obesity or congenital hypothalamic obesity achieved ...

Rhythm Pharmaceuticals (RYTM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

The Prader Willi Syndrome (PWS) has been described clinically as: obesity, hypotonia, acromicria, and mental retardation. The eating disorder is currently thought to have a hypothalamic basis.

Analyst Whitney Ijem of Canaccord Genuity maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report), retaining the price ...

The discovery of BNC2 neurons has broad implications for tackling obesity and metabolic disorders ... Tan et al, Leptin-activated hypothalamic BNC2 neurons acutely suppress food intake, Nature ...

The hypothalamus, a critical brain structure ... with female offspring exhibiting greater susceptibility to metabolic ...

Adrenal steroidogenesis is under the control of the hypothalamic–pituitary–adrenal (HPA) axis. Furthermore, metabolic factors including insulin and obesity ... and eating disorders in women ...

Genetic analysis has identified the melanocortin 4 receptor (MC4R) of the paraventricular nucleus of the hypothalamus as ... of several rare genetic obesity disorders. Agouti-related peptide ...